Latest Food & Drug Administration news
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects
posted April 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
HHS, FDA Offer Timeline for Phasing Out Petroleum-Based Food Dyes
posted April 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Announces Plan to Phase Out Some Animal Testing
posted April 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women 
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
